Search alternatives:
point decrease » point increase (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
i point » _ point (Expand Search), 5 point (Expand Search), a point (Expand Search)
point decrease » point increase (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
i point » _ point (Expand Search), 5 point (Expand Search), a point (Expand Search)
-
961
-
962
Immunoblotting FOXO1 and insulin receptors.
Published 2024“…<p>FOXO1 was significantly increased in the sitagliptin non-ischemic group (SIT-N) compared to the control non-ischemic (CON-N) myocardium. pFOXO1 was significantly decreased in the sitagliptin ischemic group (SIT-I) compared to SIT-N. …”
-
963
-
964
-
965
-
966
-
967
Drp1<sup>SD</sup> overexpression in Opa1 or Marf depleted type II NBs rescues the reduced mitochondrial membrane potential.
Published 2022“…<p>A, B: Representative images showing decreased TMRM intensity in <i>opa1</i> RNAi and <i>marf</i> RNAi expressing type II NBs. …”
-
968
Flow chart of the expression-based functional screen, with validation steps.
Published 2022Subjects: -
969
-
970
-
971
-
972
-
973
-
974
-
975
-
976
Lithium Decreases Glial Fibrillary Acidic Protein in a Mouse Model of Alexander Disease
Published 2015“…Lithium reduced the levels of phosphorylated STAT3, suggesting this as one pathway mediating the effects on GFAP. In conclusion, lithium has the potential to decrease GFAP levels in Alexander disease, but with a narrow therapeutic window separating efficacy and toxicity.…”
-
977
-
978
-
979
-
980